+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
186268-78-0,MFCD02179274
Catalog No.:AA00AK8F

186268-78-0 | (S)-1-(3,3-Dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
95%
1 week  
$134.00   $94.00
- +
5mg
95%
1 week  
$244.00   $171.00
- +
10mg
95%
1 week  
$340.00   $238.00
- +
25mg
95%
1 week  
$578.00   $404.00
- +
50mg
95%
1 week  
$826.00   $578.00
- +
500mg
>97%
1 week  
$838.00   $587.00
- +
1g
>97%
1 week  
$1,212.00   $848.00
- +
5g
>97%
1 week  
$4,702.00   $3,291.00
- +
10g
>97%
1 week  
$8,192.00   $5,734.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00AK8F
Chemical Name:
(S)-1-(3,3-Dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylic acid
CAS Number:
186268-78-0
Molecular Formula:
C12H19NO4
Molecular Weight:
241.2836
MDL Number:
MFCD02179274
SMILES:
CCC(C(=O)C(=O)N1CCC[C@H]1C(=O)O)(C)C
Properties
Computed Properties
 
Complexity:
348  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.5  

Literature

Title: Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.

Journal: Archives of neurology 20090901

Title: A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.

Journal: Neurology 20070102

Title: GPI-1485 (Guilford).

Journal: Current opinion in investigational drugs (London, England : 2000) 20040101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 186268-78-0
10148-81-9

10148-81-9

 33996-33-7

33996-33-7

 13485-59-1

13485-59-1

 62571-86-2

62571-86-2

 704-15-4

704-15-4

 68-95-1

68-95-1
Building Blocks
More >
Historical Records
852916-97-3

852916-97-3

 2126178-11-6

2126178-11-6

 868678-57-3

868678-57-3

 2363756-50-5

2363756-50-5

 313229-95-7

313229-95-7

 101387-97-7

101387-97-7
Tags:186268-78-0 Molecular Formula|186268-78-0 MDL|186268-78-0 SMILES|186268-78-0 (S)-1-(3,3-Dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylic acid
Catalog No.: AA00AK8F
186268-78-0,MFCD02179274
186268-78-0 | (S)-1-(3,3-Dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylic acid
Pack Size： 1mg
Purity： 95%
1 week
$134.00 $94.00
Pack Size： 5mg
Purity： 95%
1 week
$244.00 $171.00
Pack Size： 10mg
Purity： 95%
1 week
$340.00 $238.00
Pack Size： 25mg
Purity： 95%
1 week
$578.00 $404.00
Pack Size： 50mg
Purity： 95%
1 week
$826.00 $578.00
Pack Size： 500mg
Purity： >97%
1 week
$838.00 $587.00
Pack Size： 1g
Purity： >97%
1 week
$1,212.00 $848.00
Pack Size： 5g
Purity： >97%
1 week
$4,702.00 $3,291.00
Pack Size： 10g
Purity： >97%
1 week
$8,192.00 $5,734.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00AK8F
Chemical Name: (S)-1-(3,3-Dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylic acid
CAS Number: 186268-78-0
Molecular Formula: C12H19NO4
Molecular Weight: 241.2836
MDL Number: MFCD02179274
SMILES: CCC(C(=O)C(=O)N1CCC[C@H]1C(=O)O)(C)C
Properties
Complexity: 348  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 17  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.5  
Literature fold

Title: Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.

Journal: Archives of neurology20090901

Title: A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.

Journal: Neurology20070102

Title: GPI-1485 (Guilford).

Journal: Current opinion in investigational drugs (London, England : 2000)20040101

Related Products of of 186268-78-0
10148-81-9
10148-81-9
33996-33-7
33996-33-7
13485-59-1
13485-59-1
62571-86-2
62571-86-2
704-15-4
704-15-4
68-95-1
68-95-1
Building Blocks More >
151870-74-5
151870-74-5
Kinsenoside
AA00AKLV | MFCD11100290
17041-36-0
17041-36-0
O-(2-Acetamido-2-deoxy-D-glucopyranosyl)-L-serine
AA00AL6D | MFCD28044024
183990-48-9
183990-48-9
(S)-3-((tert-Butoxycarbonyl)amino)pentanoic acid
AA00ALIU | MFCD08275907
183742-29-2
183742-29-2
1-tert-Butyl 3-ethyl piperazine-1,3-dicarboxylate
AA00AMKR | MFCD13172266
174222-78-7
174222-78-7
(R)-2-(dimethylamino)-3-phenylpropanoic acid
AA00AMZC | MFCD20638377
164518-96-1
164518-96-1
3-(4-piperidinyl)-2-Oxazolidinone
AA00ANFN | MFCD11040536
1865-83-4
1865-83-4
7-Methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2(1h)-one
AA00ANSV | MFCD20274514
153435-86-0
153435-86-0
1-Bromo-3-(ethanesulfinyl)benzene
AA00AO5V | MFCD20529458
183204-72-0
183204-72-0
Tipiracil hydrochloride
AA00AOI5 | MFCD01571384
15307-78-5
15307-78-5
Diclofenac methyl ester
AA00AORV | MFCD08273811
Historical Records
852916-97-3
852916-97-3
2126178-11-6
2126178-11-6
868678-57-3
868678-57-3
2363756-50-5
2363756-50-5
313229-95-7
313229-95-7
101387-97-7
101387-97-7
Submit
© 2017 AA BLOCKS, INC. All rights reserved.